Skip to search.
 TSX Up 0.24% TSX Ventures Up 0.49%

Pluristem Therapeutics, Inc. (PSTI)

-NasdaqCM
1.53 Up 0.02(1.32%) Jul 22, 4:00PM EDT
Prev Close:1.51
Open:1.51
Bid:1.49 x 2000
Ask:1.52 x 200
1y Target Est:4.17
Beta:0.097713
Next Earnings Date:N/A
Day's Range:1.51 - 1.53
52wk Range:0.71 - 2.45
Volume:75,399
Avg Vol (3m):129,397
Market Cap:122.65M
P/E (ttm):N/A
EPS (ttm):-0.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
PSTIUp 1.32%122.65M
OSIRDown 1.54%176.74M
ASTM 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):41.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-16) :-0.30
Quarterly EPS Est (Jun-16) :-0.09
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pluristem Therapeutics Inc., through its subsidiary, Pluristem Ltd., operates as a bio-therapeutics company in Israel. The company focuses on the research, development, clinical trial, and manufacture of cell therapeutics products and related tech... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback